Gene · 2887
Papers1,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| GRB10 is a novel oncogene associated with cell proliferation and prognosis in glioma. | Cancer Cell Int | 2022 | 35790975 | PubTator, text mining | PubMed |
| A genome-wide screen for resilient responses in growing pigs. | Genet Sel Evol | 2022 | 35787790 | PubTator, text mining | PubMed |
| The Landscape of Exosome-Derived Non-Coding RNA in Leukemia. | Front Pharmacol | 2022 | 35784717 | PubTator, text mining | PubMed |
| Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer. | Medicine (Baltimore) | 2022 | 35776987 | PubTator, text mining | PubMed |
| A dual-activity topoisomerase complex regulates mRNA translation and turnover. | Nucleic Acids Res | 2022 | 35748872 | PubTator, text mining | PubMed |
| Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders. | Cell Prolif | 2022 | 35735243 | PubTator, text mining | PubMed |
| MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer. | Commun Biol | 2022 | 35710947 | PubTator, text mining | PubMed |
| Different types of reactions to E7386 among colorectal cancer patient-derived organoids and corresponding CAFs. | Oncol Lett | 2022 | 35707761 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Cannabis alters DNA methylation at maternally imprinted and autism candidate genes in spermatogenic cells. | Syst Biol Reprod Med | 2022 | 35687495 | PubTator, text mining | PubMed |
| Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. | Front Immunol | 2022 | 35663995 | PubTator, text mining | PubMed |
| Abplatin(IV) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin. | J Nanobiotechnology | 2022 | 35659243 | PubTator, text mining | PubMed |
| Genetics of early-life head circumference and genetic correlations with neurological, psychiatric and cognitive outcomes. | BMC Med Genomics | 2022 | 35659227 | PubTator, text mining | PubMed |
| Novel targets in rectal cancer by considering lncRNA-miRNA-mRNA network in response to Lactobacillus acidophilus consumption: a randomized clinical trial. | Sci Rep | 2022 | 35654932 | PubTator, text mining | PubMed |
| Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched. | Pharmaceutics | 2022 | 35631574 | PubTator, text mining | PubMed |
| Epigenetic Effect of Maternal Methyl-Group Donor Intake on Offspring's Health and Disease. | Life (Basel) | 2022 | 35629277 | PubTator, text mining | PubMed |
| Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes. | Front Immunol | 2022 | 35603204 | PubTator, text mining | PubMed |
| Aberrant hypomethylation at imprinted differentially methylated regions is involved in biparental placental mesenchymal dysplasia. | Clin Epigenetics | 2022 | 35581658 | PubTator, text mining | PubMed |
| Prolonged deprivation of arginine or leucine induces PI3K/Akt-dependent reactivation of mTORC1. | J Biol Chem | 2022 | 35577075 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2887/papers?page=12